The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Effectiveness of Positron Emission Tomography for the Detection of Melanoma Metastases
Open accessAbstract
OBJECTIVE: The purpose of this study was to determine the sensitivity, specificity, and clinical utility of 18F 2-fluoro-2-deoxy-D-glucose (FDG) total-body positron emission tomography (PET) scanning for the detection of metastases in patients with malignant melanoma. SUMMARY BACKGROUND DATA: Recent preliminary reports suggest that PET using FDG may be more sensitive and specific for detection of metastatic melanoma than standard radiologic imaging studies using computed tomography (CT). PET technology is showing utility in the detection of metastatic tumors from multiple primary sites including breast, lung, lymphoma, and melanoma. However, little information is available concerning the general utility, sensitivity, and specificity of PET scanning of patients with metastatic melanoma. METHODS: One hundred three PET scans done on 76 nonrandomized patients having AJCC stage II to IV melanoma were prospectively evaluated. Patients were derived from two groups. Group 1 (63 patients) had PET, CT (chest and abdomen), and magnetic resonance imaging (MRI; brain) scans as a part of staging requirements for immunotherapy protocols. Group 2 (13 nonprotocol patients) had PET, CT, and MRI scans as in group 1, but for clinical evaluation only. PET scans were done using 12 to 20 mCi of FDG given intravenously. Results of PET scans were compared to CT scans and biopsy or cytology results. RESULTS: PET scanning for the detection of melanoma metastases had a sensitivity of 94.2% and a specificity of 83.3% compared to 55.3% and 84.4%, respectively, for CT scanning. Factors that produced false-positive PET scans were papillary carcinoma of the thyroid (1), bronchogenic carcinoma (1), inflamed epidermal cyst (1), Warthin's tumor of the parotid gland (1), surgical wound inflammation (2), leiomyoma of the uterus (1), suture granuloma (1), and endometriosis (1). The four false-negative scans were thought to be due to smaller (<0.3 to 0.5 cm) and diffuse areas of melanoma without a mass effect. CONCLUSIONS: PET scanning is extremely sensitive (94.2%) and very specific (83.3%) for identifying metastatic melanoma, particularly in soft tissues, lymph nodes, and the liver. A number of second primary or metastatic tumors and an inflammatory response can also be localized by PET. This observation mandates a close clinical correlation with positive PET and emphasizes the importance of establishing a tissue diagnosis. False-negative scans in the presence of metastases are rare (4% of scans). Metastases < or =5 mm in diameter may not image well. PET is superior to CT in detecting melanoma metastases and has a role as a primary strategy in the staging of melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1996) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.46.1.5 · Cited by 1,759
Som, P., Atkins, H. L., Bandoypadhyay, D., Fowler, J. S., MacGregor, R. R., Matsui, K., Oster, Z. H., Sacker, D. F., Shiue, C. Y., Turner, H., et al. (1980) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198012000-00045 · Cited by 504
Okazumi, S., Isono, K., Enomoto, K., Kikuchi, T., Ozaki, M., Yamamoto, H., Hayashi, H., Asano, T., & Ryu, M. (1992) · PubMed · Cited by 257
Schiepers, C., Penninckx, F., De Vadder, N., Merckx, E., Mortelmans, L., Bormans, G., Marchal, G., Filez, L., & Aerts, R. (1995) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/s0748-7983(95)97046-0 · Cited by 235
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver
Vitola, J. V., Delbeke, D., Sandler, M. P., Campbell, M. G., Powers, T. A., Wright, J. K., Chapman, W. C., & Pinson, C. W. (1996) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80067-1 · Cited by 228
Avril, N., Dose, J., Janicke, F., Ziegler, S., Romer, W., Weber, W., Herz, M., Nathrath, W., Graeff, H., & Schwaiger, M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.17.1204 · Cited by 213
Bailet, J. W., Abemayor, E., Jabour, B. A., Hawkins, R. A., Ho, C., & Ward, P. H. (1992) · The Laryngoscope · doi:10.1288/00005537-199203000-00010 · Cited by 204
Steinert, H. C., Böni, R. A. H., Buck, A., Böni, R., Berthold, T., Marinček, B., Burg, G., & von Schulthess, G. (1995) · Radiology · doi:10.1148/radiology.195.3.7753998 · Cited by 193
Scott, W. J., Gobar, L. S., Terry, J. D., Dewan, N. A., & Sunderland, J. J. (1996) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70317-3 · Cited by 182
Lapela, M., Leskinen, S., Minn, H., Lindholm, P., Klemi, P., Soderstrom, K., Bergman, J., Haaparanta, M., Ruotsalainen, U., & Solin, O. (1995) · Blood · doi:10.1182/blood.v86.9.3522.bloodjournal8693522 · Cited by 174
Cited by
(2001) · PubMed · Cited by 943
Clinical Role of FDG PET in Evaluation of Cancer Patients
Kostakoglu, L., Agress, H., & Goldsmith, S. J. (2003) · RadioGraphics · doi:10.1148/rg.232025705 · Cited by 402
Blodgett, T. M., Meltzer, C. C., & Townsend, D. W. (2007) · Radiology · doi:10.1148/radiol.2422051113 · Cited by 387
Reske, S. N., & Kotzerke, J. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100626 · Cited by 365
Bar-Shalom, R., Valdivia, A. Y., & Blaufox, M. D. (2000) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2000.7439 · Cited by 340
Metadata
- Authors
- Holder, W. D., White, R. L., Zuger, J. H., Easton, E. J., & Greene, F. L.
- Venue
- Annals of Surgery
- Published
- 1998-05
- Volume
- 227
- Issue
- 5
- Pages
- 764-771
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W1974483691
- Cited by
- 264
- References
- 17
- FWCI
- 17.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness of Positron Emission Tomography for the Detection of Melanoma Metastases. https://app.cochat.ai/papers/10.1097/00000658-199805000-00017
- The paper
- Holder, W. D., White, R. L., Zuger, J. H., Easton, E. J., & Greene, F. L. (1998). Effectiveness of Positron Emission Tomography for the Detection of Melanoma Metastases. Annals of Surgery. https://doi.org/10.1097/00000658-199805000-00017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.